D-Wave Quantum: A $503 Million War Chest, a 19% Bookings Slide and Two Cut Price Targets
Published on 11/17/2026 at 13:02 | Editorial boerse-global.deD-Wave Quantum's third-quarter report, released on 10 November for the period ended 30 September 2026, sets up an awkward contrast for anyone weighing the stock: revenue is climbing while fresh orders are shrinking. The company filed its Form 10-Q for the quarter yesterday, but the operating picture has not changed. Sales came in at $4.5 million, up 21% year on year. Bookings, by contrast, fell 19% to $1.9 million.
Monday's market response was blunt. The shares shed 8.8% as investors digested the bookings decline.
The Nine-Month Number Cuts the Other Way
Look beyond the single quarter and the story flips. Bookings over the first nine months of 2026 reached $37.4 million, a 611% jump on the prior-year figure. That gap between the short and long view sits at the heart of the debate. Anyone betting on a rebound leans on the nine-month surge; anyone holding back wants the quarterly trend to turn first. Neither reading cancels the other out — both are drawn from the same reported figures.
Timing of revenue recognition adds a further wrinkle. Rosenblatt cut its price target on 11 November from $43 to $30, citing uncertainty over how revenue lands quarter by quarter and a slower ramp in the QCaaS business. The broker kept its buy rating, pairing a constructive overall view with tempered expectations on pace. The takeaway for investors: it is not just the prospect of growth that matters, but how reliably it can be timed.
StoneX followed on Thursday, trimming its target from $30 to $20 while also sticking with a buy recommendation. That combination argues for a nuanced read — a positive rating does nothing to erase the loss risk or the uncertainty around the revenue trajectory.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
Cash Is Room to Manoeuvre, Not Demand
As of 30 September 2026, D-Wave reported $503.4 million in cash and marketable securities. That cushion is a genuine argument for anyone willing to give the company time to develop. Liquidity and commercial success, however, are different things. The money buys breathing room; it does not manufacture orders.
The more important question is whether D-Wave can win enough business to eventually make its heavy losses weigh less. On that front, the latest bookings give no clear signal. Remaining performance obligations stood at $38.3 million at the end of September — a useful supplementary metric, though not the same as revenue already booked. Converting those obligations into sales would help; so would a pickup in new orders.
There is also a binding agreement with the US Department of Commerce for access to up to $100 million under the CHIPS and Science Act. That access is tied to hitting milestones, so it is neither cash in hand nor an unconditional inflow. In the best case, D-Wave meets the conditions and unlocks extra headroom — but new orders would still have to show that the commercial side is moving forward.
Losses Sharpen the Demand Problem
The bear case carries real weight. A weaker order intake bites harder when the underlying business is still burning through cash. Net loss for the quarter came to $48.2 million, or $0.13 per share, against analyst expectations of a $0.10 loss. The adjusted EBITDA loss was $37.7 million.
Revenue growth, in other words, did not come with a positive result — and the earnings line missed forecasts as well. Investors should watch more than rising sales; the ratio between business volume and losses has to improve. Without that, even an order rebound would only partly offset the economic concerns. If bookings stay weak and revenue recognition slows, the case for a swift operating turnaround gets harder to make.
What Would Settle the Argument
A concrete catalyst would be a new contract with verifiable volume and clear terms. For a more durable re-rating, revenue conversion and earnings would need to move in step. The question is not whether D-Wave can post growth — it can — but whether that growth turns into a steadier business.
D-Wave has confirmed it will attend the RBC Capital Markets Global TMT Conference in New York City. Commentary there on bookings, the execution of existing obligations and the CHIPS milestones would carry more weight than anything said so far. The conference itself is neither a signed deal nor a confirmed grant payment. What matters is whether the company can narrow the gap between its financial resources and its commercial progress — and that is the yardstick by which the stock should be judged.
Ad
D-Wave Quantum Stock: New Analysis - 17 November
Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
